Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans.

Obesity research & clinical practice

Kobayashi N, Masuzaki H, Tanaka T, Yasue S, Ishii T, Tomita T, Miyawaki T, Komeda T, Fukuda Y, Kusakabe T, Noguchi M, Fujikura J, Ebihara K, Hirata M, Hosoda K, Satoh N, Nakajima M, Okabayashi Y, Shun Sato T, Nakao K.
PMID: 24345559
Obes Res Clin Pract. 2009 May;3(2):I-II. doi: 10.1016/j.orcp.2008.11.002.

OBJECTIVE: Dysregulation of tissue-specific intracellular glucocorticoid reactivation is implicated in obesity and related metabolic diseases in humans. The ratio of end products of glucocorticoid metabolism in fresh urine sample, tetrahydrocortisol (THF) + allo-tetrahydrocortisol (allo-THF) vs. tetrahydrocortisone (THE), i.e., the...

Cite
Kobayashi N, Masuzaki H, Tanaka T, et al. Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans. Obes Res Clin Pract. 2009;3(2):I-IIdoi: 10.1016/j.orcp.2008.11.002.
Kobayashi, N., Masuzaki, H., Tanaka, T., Yasue, S., Ishii, T., Tomita, T., Miyawaki, T., Komeda, T., Fukuda, Y., Kusakabe, T., Noguchi, M., Fujikura, J., Ebihara, K., Hirata, M., Hosoda, K., Satoh, N., Nakajima, M., Okabayashi, Y., Shun Sato, T., & Nakao, K. (2009). Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans. Obesity research & clinical practice, 3(2), I-II. https://doi.org/10.1016/j.orcp.2008.11.002
Kobayashi, Nozomi, et al. "Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans." Obesity research & clinical practice vol. 3,2 (2009): I-II. doi: https://doi.org/10.1016/j.orcp.2008.11.002
Kobayashi N, Masuzaki H, Tanaka T, Yasue S, Ishii T, Tomita T, Miyawaki T, Komeda T, Fukuda Y, Kusakabe T, Noguchi M, Fujikura J, Ebihara K, Hirata M, Hosoda K, Satoh N, Nakajima M, Okabayashi Y, Shun Sato T, Nakao K. Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans. Obes Res Clin Pract. 2009 May;3(2):I-II. doi: 10.1016/j.orcp.2008.11.002. PMID: 24345559.
Copy Download .nbib Format: NLM
LC-MS/MS Method for the Simultaneous Determination of Free Urinary Steroids.

Chromatographia

Allende F, Solari S, Campino C, Carvajal CA, Lagos CF, Vecchiola A, Valdivia C, Baudrand R, Owen GI, Fardella CE.
PMID: 24683202
Chromatographia. 2014;77:637-642. doi: 10.1007/s10337-014-2638-4. Epub 2014 Feb 11.

Cortisol homeostasis is implicated in hypertension and metabolic syndrome. Two enzymes modulate cortisol availability; 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) preferentially converts inactive cortisone to cortisol, whereas 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) converts cortisol to cortisone. In contrast, 5α and...

Cite
Allende F, Solari S, Campino C, et al. LC-MS/MS Method for the Simultaneous Determination of Free Urinary Steroids. Chromatographia. 2014;77:637-642doi: 10.1007/s10337-014-2638-4.
Allende, F., Solari, S., Campino, C., Carvajal, C. A., Lagos, C. F., Vecchiola, A., Valdivia, C., Baudrand, R., Owen, G. I., & Fardella, C. E. (2014). LC-MS/MS Method for the Simultaneous Determination of Free Urinary Steroids. Chromatographia, 77637-642. https://doi.org/10.1007/s10337-014-2638-4
Allende, Fidel, et al. "LC-MS/MS Method for the Simultaneous Determination of Free Urinary Steroids." Chromatographia vol. 77 (2014): 637-642. doi: https://doi.org/10.1007/s10337-014-2638-4
Allende F, Solari S, Campino C, Carvajal CA, Lagos CF, Vecchiola A, Valdivia C, Baudrand R, Owen GI, Fardella CE. LC-MS/MS Method for the Simultaneous Determination of Free Urinary Steroids. Chromatographia. 2014;77:637-642. doi: 10.1007/s10337-014-2638-4. Epub 2014 Feb 11. PMID: 24683202; PMCID: PMC3967076.
Copy Download .nbib Format: NLM
Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study.

BMJ open ophthalmology

Schwab D, Sturm C, Portron A, Fuerst-Recktenwald S, Hainzl D, Jordan P, Stewart WC, Tepedino ME, DuBiner H.
PMID: 29354707
BMJ Open Ophthalmol. 2017 Jun 29;1(1):e000063. doi: 10.1136/bmjophth-2016-000063. eCollection 2017.

BACKGROUND/AIMS: Cortisol is involved in the regulation of intraocular pressure (IOP). This study aimed to assess the effect of 11β-hydroxysteroid-dehydrogenase type 1 (11βHSD1) inhibition by oral administration of RO5093151 on IOP.METHODS: The exposure of key ocular compartments following oral...

Cite
Schwab D, Sturm C, Portron A, et al. Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ Open Ophthalmol. 2017;1(1):e000063doi: 10.1136/bmjophth-2016-000063.
Schwab, D., Sturm, C., Portron, A., Fuerst-Recktenwald, S., Hainzl, D., Jordan, P., Stewart, W. C., Tepedino, M. E., & DuBiner, H. (2017). Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ open ophthalmology, 1(1), e000063. https://doi.org/10.1136/bmjophth-2016-000063
Schwab, Dietmar, et al. "Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study." BMJ open ophthalmology vol. 1,1 (2017): e000063. doi: https://doi.org/10.1136/bmjophth-2016-000063
Schwab D, Sturm C, Portron A, Fuerst-Recktenwald S, Hainzl D, Jordan P, Stewart WC, Tepedino ME, DuBiner H. Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ Open Ophthalmol. 2017 Jun 29;1(1):e000063. doi: 10.1136/bmjophth-2016-000063. eCollection 2017. PMID: 29354707; PMCID: PMC5721631.
Copy Download .nbib Format: NLM
Maternal Signatures of Cortisol in First Trimester Small-for-Gestational Age.

Reproductive sciences (Thousand Oaks, Calif.)

Lee C, Lee SM, Byun DJ, Kim SY, Kim HI, Lee DY, Jung YM, Park CW, Park JS, Choi MH.
PMID: 35001327
Reprod Sci. 2022 Jan 10; doi: 10.1007/s43032-021-00822-w. Epub 2022 Jan 10.

The objective of this study was to identify predictable maternal serum signatures of cortisol metabolism during the first trimester of women who are expected to deliver small-for-gestational-age (SGA) neonates. This prospective cohort study included 112 pregnant women (with and...

Cite
Lee C, Lee SM, Byun DJ, et al. Maternal Signatures of Cortisol in First Trimester Small-for-Gestational Age. Reprod Sci. 2022;doi: 10.1007/s43032-021-00822-w.
Lee, C., Lee, S. M., Byun, D. J., Kim, S. Y., Kim, H. I., Lee, D. Y., Jung, Y. M., Park, C. W., Park, J. S., & Choi, M. H. (2022). Maternal Signatures of Cortisol in First Trimester Small-for-Gestational Age. Reproductive sciences (Thousand Oaks, Calif.), . https://doi.org/10.1007/s43032-021-00822-w
Lee, Chaelin, et al. "Maternal Signatures of Cortisol in First Trimester Small-for-Gestational Age." Reproductive sciences (Thousand Oaks, Calif.) vol. (2022). doi: https://doi.org/10.1007/s43032-021-00822-w
Lee C, Lee SM, Byun DJ, Kim SY, Kim HI, Lee DY, Jung YM, Park CW, Park JS, Choi MH. Maternal Signatures of Cortisol in First Trimester Small-for-Gestational Age. Reprod Sci. 2022 Jan 10; doi: 10.1007/s43032-021-00822-w. Epub 2022 Jan 10. PMID: 35001327.
Copy Download .nbib Format: NLM
Urinary Steroid Profile in Ironman Triathletes.

Journal of human kinetics

Marcos-Serrano M, Olcina G, Crespo C, Brooks D, Timon R.
PMID: 29599864
J Hum Kinet. 2018 Mar 23;61:109-117. doi: 10.1515/hukin-2017-0130. eCollection 2018 Mar.

The aim of this study was to determine variations in the urinary steroid profile of triathletes following an Ironman event. A total of 10 male participants (age = 36.0 ± 1.27 years; body height = 179.29 ± 10.77 cm;...

Cite
Marcos-Serrano M, Olcina G, Crespo C, et al. Urinary Steroid Profile in Ironman Triathletes. J Hum Kinet. 2018;61:109-117doi: 10.1515/hukin-2017-0130.
Marcos-Serrano, M., Olcina, G., Crespo, C., Brooks, D., & Timon, R. (2018). Urinary Steroid Profile in Ironman Triathletes. Journal of human kinetics, 61109-117. https://doi.org/10.1515/hukin-2017-0130
Marcos-Serrano, Marta, et al. "Urinary Steroid Profile in Ironman Triathletes." Journal of human kinetics vol. 61 (2018): 109-117. doi: https://doi.org/10.1515/hukin-2017-0130
Marcos-Serrano M, Olcina G, Crespo C, Brooks D, Timon R. Urinary Steroid Profile in Ironman Triathletes. J Hum Kinet. 2018 Mar 23;61:109-117. doi: 10.1515/hukin-2017-0130. eCollection 2018 Mar. PMID: 29599864; PMCID: PMC5873341.
Copy Download .nbib Format: NLM
Tetrahydro-derivatives of cortisone promote granulomatous tissue angiogenesis in vivo on topical application in hyaluronan.

Angiogenesis

Alam C, Colville-Nash P, Seed MP, Willoughby D.
PMID: 14517384
Angiogenesis. 1998;1(2):185-191. doi: 10.1023/A:1018329705172.

Hyaluronan is an essential component of the extracellular matrix and alters the quality of wound healing as well as modulating angiogenesis. It is also used as a topical and i.v. drug delivery system. We have previously reported that cortisone...

Cite
Alam C, Colville-Nash P, Seed MP, et al. Tetrahydro-derivatives of cortisone promote granulomatous tissue angiogenesis in vivo on topical application in hyaluronan. Angiogenesis. 1998;1(2):185-191doi: 10.1023/A:1018329705172.
Alam, C., Colville-Nash, P., Seed, M. P., & Willoughby, D. (1998). Tetrahydro-derivatives of cortisone promote granulomatous tissue angiogenesis in vivo on topical application in hyaluronan. Angiogenesis, 1(2), 185-191. https://doi.org/10.1023/A:1018329705172
Alam, Chandan, et al. "Tetrahydro-derivatives of cortisone promote granulomatous tissue angiogenesis in vivo on topical application in hyaluronan." Angiogenesis vol. 1,2 (1998): 185-191. doi: https://doi.org/10.1023/A:1018329705172
Alam C, Colville-Nash P, Seed MP, Willoughby D. Tetrahydro-derivatives of cortisone promote granulomatous tissue angiogenesis in vivo on topical application in hyaluronan. Angiogenesis. 1998;1(2):185-191. doi: 10.1023/A:1018329705172. PMID: 14517384.
Copy Download .nbib Format: NLM
The biliary accumulation of corticosteroids in rainbow trout,Oncorhynchus mykiss, during acute and chronic stress.

Fish physiology and biochemistry

Pottinger TG, Moran TA, Cranwell PA.
PMID: 24214195
Fish Physiol Biochem. 1992 May;10(1):55-66. doi: 10.1007/BF00004654.

The accumulation of immunoreactive corticosteroids in the bile of rainbow trout during stress was monitored by radioimmunoassay and GUMS. Although plasma cortisol levels were elevated by confinement for 1 hour, biliary levels of free and conjugated steroids in the...

Cite
Pottinger TG, Moran TA, Cranwell PA. The biliary accumulation of corticosteroids in rainbow trout,Oncorhynchus mykiss, during acute and chronic stress. Fish Physiol Biochem. 1992;10(1):55-66doi: 10.1007/BF00004654.
Pottinger, T. G., Moran, T. A., & Cranwell, P. A. (1992). The biliary accumulation of corticosteroids in rainbow trout,Oncorhynchus mykiss, during acute and chronic stress. Fish physiology and biochemistry, 10(1), 55-66. https://doi.org/10.1007/BF00004654
Pottinger, T G, et al. "The biliary accumulation of corticosteroids in rainbow trout,Oncorhynchus mykiss, during acute and chronic stress." Fish physiology and biochemistry vol. 10,1 (1992): 55-66. doi: https://doi.org/10.1007/BF00004654
Pottinger TG, Moran TA, Cranwell PA. The biliary accumulation of corticosteroids in rainbow trout,Oncorhynchus mykiss, during acute and chronic stress. Fish Physiol Biochem. 1992 May;10(1):55-66. doi: 10.1007/BF00004654. PMID: 24214195.
Copy Download .nbib Format: NLM
Height Velocity defined metabolic Control in Children with Congenital Adrenal Hyperplasia using urinary GC-MS Analysis.

The Journal of clinical endocrinology and metabolism

Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA.
PMID: 31112272
J Clin Endocrinol Metab. 2019 May 21; doi: 10.1210/jc.2019-00438. Epub 2019 May 21.

BACKGROUND: Treatment of children with classic congenital adrenal hyperplasia (CAH) with glucocorticoids is a difficult balance between hypercortisolism and hyperandrogenism. Biochemical monitoring of treatment is not well defined. Achievement of a normal growth rate is the most important therapeutic...

Cite
Kamrath C, Wettstaedt L, Hartmann MF, et al. Height Velocity defined metabolic Control in Children with Congenital Adrenal Hyperplasia using urinary GC-MS Analysis. J Clin Endocrinol Metab. 2019;doi: 10.1210/jc.2019-00438.
Kamrath, C., Wettstaedt, L., Hartmann, M. F., & Wudy, S. A. (2019). Height Velocity defined metabolic Control in Children with Congenital Adrenal Hyperplasia using urinary GC-MS Analysis. The Journal of clinical endocrinology and metabolism, . https://doi.org/10.1210/jc.2019-00438
Kamrath, Clemens, et al. "Height Velocity defined metabolic Control in Children with Congenital Adrenal Hyperplasia using urinary GC-MS Analysis." The Journal of clinical endocrinology and metabolism vol. (2019). doi: https://doi.org/10.1210/jc.2019-00438
Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA. Height Velocity defined metabolic Control in Children with Congenital Adrenal Hyperplasia using urinary GC-MS Analysis. J Clin Endocrinol Metab. 2019 May 21; doi: 10.1210/jc.2019-00438. Epub 2019 May 21. PMID: 31112272.
Copy Download .nbib Format: NLM
Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats.

Frontiers in endocrinology

Rougeon V, Moisan MP, Barthe N, Beauvieux MC, Helbling JC, Pallet V, Marissal-Arvy N, Barat P.
PMID: 28458655
Front Endocrinol (Lausanne). 2017 Apr 18;8:81. doi: 10.3389/fendo.2017.00081. eCollection 2017.

BACKGROUND: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is often encountered in diabetes, leading to several clinical complications. Our recent results showing an elevated tetrahydrocortisol/tetrahydrocorticosterone ratio in morning urine of diabetic children compared to that of controls suggest an increased...

Cite
Rougeon V, Moisan MP, Barthe N, et al. Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats. Front Endocrinol (Lausanne). 2017;8:81doi: 10.3389/fendo.2017.00081.
Rougeon, V., Moisan, M. P., Barthe, N., Beauvieux, M. C., Helbling, J. C., Pallet, V., Marissal-Arvy, N., & Barat, P. (2017). Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats. Frontiers in endocrinology, 881. https://doi.org/10.3389/fendo.2017.00081
Rougeon, Véronica, et al. "Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats." Frontiers in endocrinology vol. 8 (2017): 81. doi: https://doi.org/10.3389/fendo.2017.00081
Rougeon V, Moisan MP, Barthe N, Beauvieux MC, Helbling JC, Pallet V, Marissal-Arvy N, Barat P. Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats. Front Endocrinol (Lausanne). 2017 Apr 18;8:81. doi: 10.3389/fendo.2017.00081. eCollection 2017. PMID: 28458655; PMCID: PMC5394469.
Copy Download .nbib Format: NLM
Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?.

Clinical endocrinology

Brossaud J, Ducint D, Corcuff JB.
PMID: 25571968
Clin Endocrinol (Oxf). 2016 Feb;84(2):236-243. doi: 10.1111/cen.12717. Epub 2015 Feb 20.

OBJECTIVE: Total urinary cortisol metabolites represent cortisol production and metabolism. We hypothesized that to assay metabolites could add some information to the one provided by a sole cortisol assay.DESIGN AND PATIENTS: We set up an inexpensive multiplex mass spectrometry...

Cite
Brossaud J, Ducint D, Corcuff JB. Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?. Clin Endocrinol (Oxf). 2015;84(2):236-243doi: 10.1111/cen.12717.
Brossaud, J., Ducint, D., & Corcuff, J. B. (2016). Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?. Clinical endocrinology, 84(2), 236-243. https://doi.org/10.1111/cen.12717
Brossaud, Julie, et al. "Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?." Clinical endocrinology vol. 84,2 (2016): 236-243. doi: https://doi.org/10.1111/cen.12717
Brossaud J, Ducint D, Corcuff JB. Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?. Clin Endocrinol (Oxf). 2016 Feb;84(2):236-243. doi: 10.1111/cen.12717. Epub 2015 Feb 20. PMID: 25571968.
Copy Download .nbib Format: NLM
The relation between the aging of the steroid generating system and the geneses of cancers of the stomach, the breast and the uterine cervix.

Oncology reports

Kodama M, Murakami M, Kodama T.
PMID: 21594438
Oncol Rep. 1996 Jul;3(4):695-705. doi: 10.3892/or.3.4.695.

The purpose of the present study is to test the validity of the steroid carcinogenesis hypothesis in humans by investigating the problem whether or not a cancer-specific change of the hormonal milieu emerges at a specified stage of life...

Cite
Kodama M, Murakami M, Kodama T. The relation between the aging of the steroid generating system and the geneses of cancers of the stomach, the breast and the uterine cervix. Oncol Rep. 1996;3(4):695-705doi: 10.3892/or.3.4.695.
Kodama, M., Murakami, M., & Kodama, T. (1996). The relation between the aging of the steroid generating system and the geneses of cancers of the stomach, the breast and the uterine cervix. Oncology reports, 3(4), 695-705. https://doi.org/10.3892/or.3.4.695
Kodama, M, et al. "The relation between the aging of the steroid generating system and the geneses of cancers of the stomach, the breast and the uterine cervix." Oncology reports vol. 3,4 (1996): 695-705. doi: https://doi.org/10.3892/or.3.4.695
Kodama M, Murakami M, Kodama T. The relation between the aging of the steroid generating system and the geneses of cancers of the stomach, the breast and the uterine cervix. Oncol Rep. 1996 Jul;3(4):695-705. doi: 10.3892/or.3.4.695. PMID: 21594438.
Copy Download .nbib Format: NLM
Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.

Frontiers in endocrinology

De Santis D, Castagna A, Danese E, Udali S, Martinelli N, Morandini F, Veneri M, Bertolone L, Olivieri O, Friso S, Pizzolo F.
PMID: 34497581
Front Endocrinol (Lausanne). 2021 Aug 23;12:681974. doi: 10.3389/fendo.2021.681974. eCollection 2021.

OBJECTIVE: Apparent mineralocorticoid excess (AME) is an autosomal recessive disorder caused by the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme deficiency, traditionally assessed by measuring either the urinary cortisol metabolites ratio (tetrahydrocortisol+allotetrahydrocortisol/tetrahydrocortisone, THF+5αTHF/THE) or the urinary cortisol/cortisone (F/E) ratio. Exosomal...

Cite
De Santis D, Castagna A, Danese E, et al. Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension. Front Endocrinol (Lausanne). 2021;12:681974doi: 10.3389/fendo.2021.681974.
De Santis, D., Castagna, A., Danese, E., Udali, S., Martinelli, N., Morandini, F., Veneri, M., Bertolone, L., Olivieri, O., Friso, S., & Pizzolo, F. (2021). Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension. Frontiers in endocrinology, 12681974. https://doi.org/10.3389/fendo.2021.681974
De Santis, Domenica, et al. "Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension." Frontiers in endocrinology vol. 12 (2021): 681974. doi: https://doi.org/10.3389/fendo.2021.681974
De Santis D, Castagna A, Danese E, Udali S, Martinelli N, Morandini F, Veneri M, Bertolone L, Olivieri O, Friso S, Pizzolo F. Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension. Front Endocrinol (Lausanne). 2021 Aug 23;12:681974. doi: 10.3389/fendo.2021.681974. eCollection 2021. PMID: 34497581; PMCID: PMC8419411.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries